Skip to main content
Stephen Gancher, MD, Neurology, Portland, OR

Stephen T Gancher MD FAAN

Movement Disorder


Neurologist, Kaiser Permanente

Join to View Full Profile
  • 3550 N Interstate AvePortland, OR 97227

  • Phone+1 503-285-9321

  • Fax+1 503-261-2160

Dr. Gancher is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Oregon Health & Science University (OHSU Health)
    Oregon Health & Science University (OHSU Health)Residency, Neurology, 1981 - 1987
  • Martinez Veterans Affairs Medical Center
    Martinez Veterans Affairs Medical CenterInternship, Internal Medicine, 1980 - 1981
  • Wake Forest School of Medicine of Wake Forest Baptist Medical Center
    Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 1980

Certifications & Licensure

  • OR State Medical License
    OR State Medical License 1982 - 2025
  • WA State Medical License
    WA State Medical License 1997 - 2025
  • Neurology
    American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
  • Top MD Consumers Checkbook

Publications & Presentations

PubMed

Grant Support

  • Sublingual Apomorphine In Parkinson'S Disease--Tolerability And EfficacyNational Center For Research Resources1997–1999
  • Blinded Withdrawl Of Deprenyl In Datatop EtensionNational Center For Research Resources1994–1996
  • Alterations In Dopaminergic Response In ParkinsonismNational Institute Of Neurological Disorders And Stroke1992–1996
  • Factors Controlling Tolerance To Apomorphine Treatment In Parkinson'S DiseaseNational Center For Research Resources1994
  • Comparison Of Midodrine VS Placebo In Neurogenic Orthostatic HypotensionNational Center For Research Resources1994
  • Ropinirole As Adjunct To L-DOPA In The Treatment Of Parkinson'S DiseaseNational Center For Research Resources1992–1994
  • Monitoring Parkinsonism In Patients With Complex Patterns Of ResponseNational Center For Research Resources1992–1994
  • Study Of Sinemet CR 25/100 In Parkinsonian Patients Without Prior TherapyNational Center For Research Resources1991–1993
  • Control Of Tolerance To Chronic Apomorphine Stimulation In Parkinson'S DiseaseNational Center For Research Resources1990–1993
  • Deprenyl And Tocopheral Antioxidative Therapy In ParkinsonismNational Center For Research Resources1990–1992
  • Apomorphine In Parkinson'S DiseaseNational Center For Research Resources1989–1990
  • Deprenyl And Tocopherol Antioxidative Therapy In ParkinsonismNational Center For Research Resources1988–1989
  • Apomorphine In Parkinsons DiseaseNational Center For Research Resources1988
  • Is L-DOPA Excreted In BileNational Center For Research Resources1987–1988
  • Pharmacokinetics Of Levodopa In Parkinson'S DiseaseNational Institute Of Neurological Disorders And Stroke1985–1986

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: